Updates are available Correction dated 2020-05-15
Click to view Correction: https://doi.org/10.1038/s41591-020-0923-3
Updates are available Correction dated 2023-03-21
Click to view Correction: https://doi.org/10.1038/s41591-023-02312-9
-
Authors
Powles, Thomas http://orcid.org/0000-0001-7760-4724
Kockx, Mark
Rodriguez-Vida, Alejo
Duran, Ignacio
Crabb, Simon J. http://orcid.org/0000-0003-3521-9064
Van Der Heijden, Michiel S.
Szabados, Bernadett
Pous, Albert Font
Gravis, Gwenaelle
Herranz, Urbano Anido http://orcid.org/0000-0003-0376-5642
Protheroe, Andrew http://orcid.org/0000-0001-9413-0575
Ravaud, Alain
Maillet, Denis
Mendez, Maria Jose http://orcid.org/0000-0002-7460-1859
Suarez, Cristina
Linch, Mark
Prendergast, Aaron http://orcid.org/0000-0002-9668-6689
van Dam, Pieter-Jan http://orcid.org/0000-0001-9074-8271
Stanoeva, Diana
Daelemans, Sofie
Mariathasan, Sanjeev
Tea, Joy S. http://orcid.org/0000-0002-3395-149X
Mousa, Kelly
Banchereau, Romain
Castellano, Daniel
- License Information
-
More Information
Article History
Received: 24 June 2019
Accepted: 25 September 2019
First Online: 4 November 2019
Change Date: 15 May 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Change Date: 21 March 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-023-02312-9
Competing interests
: Employment by Roche: S.M., J.S.T. and R.B.; employment by Histogenex: M.K., P.-J.v.D., D.S. and S.D.; research funding/honoraria (BMS): T.P., A.R., I.D., M.S.V.D.H., A.P. and M.L.; research funding/honoraria (Roche): T.P., A.R., I.D., M.S.V.D.H., G.G., U.A.H., M.K., A.P., A.R., M.J.M. and C.S.; research funding/honoraria (AZ): T.P., I.D., M.S.V.D.H., A.P., G.G., U.A.H., M.K. and C.S.; research funding/honoraria (MSD): T.P., I.D., S.J.C., M.S.V.D.H., M.K., D.M., C.S. and M.L.; research funding/honoraria (Pfizer): T.P., S.J.C., G.G., A.P., A.R., M.J.M. and C.S.; research funding/honoraria (Novartis): I.D., U.A.H., A.P., A.R. and C.S.; research funding/honoraria (Exelixis): T.P. and C.S.; research funding/honoraria (Astellas): T.P., S.J.C., G.G., A.P., A.R. and M.L.; research funding/honoraria (Johnson & Johnson): T.P.
